SANTA CLARA, Calif., May 08, 2019 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today reported financial results for the three months ended March 31, 2019. Recent Highlights Recognized revenue of $7.3 million […]
Financial
Endonovo Therapeutics Appoints Dr. Roc Alan McCarthy as a Scientific Advisory Board Member
Los Angeles, CA , May 09, 2019 (GLOBE NEWSWIRE) — Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced, that Roc Alan McCarthy, D.O. will be joining the company as a Scientific Advisory Board Member. Dr. McCarthy will help Endonovo continue to advance their clinical pipeline forward and contribute to the strategic […]
Silk Road Medical Reports First Quarter 2019 Financial Results
SUNNYVALE, Calif., May 08, 2019 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended March 31, 2019. Recent Highlights Recorded revenues of $12.8 million for the first quarter […]
Avinger Provides First Quarter 2019 Shareholder Update
REDWOOD CITY, Calif., May 08, 2019 (GLOBE NEWSWIRE) — Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), today reported results for the first quarter ended March 31, 2019. First […]
ARCA Biopharma Announces First Quarter 2019 Financial Results and Provides Corporate Update
WESTMINSTER, Colo., May 08, 2019 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today reported financial results for the quarter ended March 31, 2019 and provided a corporate update. “In the first part of this year, we […]
Stereotaxis and Osypka Enter Strategic Collaboration to Advance Robotic Catheter Technology
Development of next generation robotically-navigated magnetic ablation catheter fully owned by Stereotaxis Catheter designed to enhance patient care, improve therapy delivery, simplify catheter navigation, and strengthen commitment to open ecosystem Entered into additional business agreements to support a long-term broad collaboration in electrophysiology ST. LOUIS and RHEINFELDEN, Germany, May 09, […]
Corindus Reports First Quarter 2019 Results
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, today reported financial results for its first quarter ended March 31, 2019. Recent Financial Highlights and Business Accomplishments: Revenue totaled $3.0 million during the first quarter of 2019, including sale and installation of nine […]
Proteon Therapeutics Announces First Quarter 2019 Financial Results
WALTHAM, Mass., May 08, 2019 (GLOBE NEWSWIRE) — Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and vascular diseases, today announced its financial results for the quarter ended March 31, 2019, and recent events. Recent Events PATENCY-2 Trial Misses Statistical […]
SentiAR Names Berk Tas President and CEO
ST. LOUIS, May 8, 2019 /PRNewswire/ — SentiAR, a medical device startup transforming the cardiac ablation procedures, today announced that industry expert Berk Tas has joined the company as CEO and president. Tas brings to SentiAR over a decade in the healthcare medical device industry at both large organizations and startups. Tas has […]
Radcliffe Group Ltd Appoints Non-Executive Chairman and Chief Scientific Officer
LONDON, May 8, 2019 /PRNewswire/ — Radcliffe Group Ltd (“RG”) announces Professor Andrew Coats (recently Academic Vice President, Monash University and University of Warwick) as Non-Executive Chairman and Dr. Gregory Guillory as Chief Scientific Officer, effective on April 1, 2019. Professor Andrew Coats (top right) is a world-renowned Australian–British academic cardiologist who has a particular interest in the management of heart failure. His research […]



